These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 33124555)
21. Clinical subsets of juvenile dermatomyositis classified by myositis-specific autoantibodies: Experience at a single center in Japan. Iwata N; Nakaseko H; Kohagura T; Yasuoka R; Abe N; Kawabe S; Sugiura S; Muro Y Mod Rheumatol; 2019 Sep; 29(5):802-807. PubMed ID: 30092736 [No Abstract] [Full Text] [Related]
22. [Myositis-specific antibodies associated with juvenile dermatomyositis]. Eising K; Peitz J; Unterwalder N; Meisel C; Horneff G Z Rheumatol; 2018 Oct; 77(8):735-740. PubMed ID: 29411095 [TBL] [Abstract][Full Text] [Related]
23. Identification of 4 subgroups in juvenile dermatomyositis by principal component analysis-based cluster analysis. Zhang J; Xue Y; Liu X; Kuang W; Tan X; Li C; Li C Clin Exp Rheumatol; 2022 Feb; 40(2):443-449. PubMed ID: 34251318 [TBL] [Abstract][Full Text] [Related]
25. Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis. Sabbagh SE; Pinal-Fernandez I; Casal-Dominguez M; Albayda J; Paik JJ; Miller FW; Rider LG; Mammen AL; Christopher-Stine L; Clin Rheumatol; 2021 Oct; 40(10):4095-4100. PubMed ID: 33851273 [TBL] [Abstract][Full Text] [Related]
26. Autoantibody Profile of Children with Juvenile Dermatomyositis. Sharma A; Bhattarai D; Gupta A; Guleria S; Rawat A; Vignesh P; Garg R; Singh S Indian J Pediatr; 2021 Dec; 88(12):1170-1173. PubMed ID: 33694062 [TBL] [Abstract][Full Text] [Related]
27. Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset. Tansley SL; Betteridge ZE; Shaddick G; Gunawardena H; Arnold K; Wedderburn LR; McHugh NJ; Rheumatology (Oxford); 2014 Dec; 53(12):2204-8. PubMed ID: 24987158 [TBL] [Abstract][Full Text] [Related]
28. [Juvenile dermatomyositis and new autoantibodies: Cases and review]. Guarella M; Jurquet AL; Retornaz K; Bardin N; Chastang MC; Desjonquere M; Fabien N; Belot A Arch Pediatr; 2015 Dec; 22(12):1263-7. PubMed ID: 26598044 [TBL] [Abstract][Full Text] [Related]
29. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. Gunawardena H; Wedderburn LR; North J; Betteridge Z; Dunphy J; Chinoy H; Davidson JE; Cooper RG; McHugh NJ; Rheumatology (Oxford); 2008 Mar; 47(3):324-8. PubMed ID: 18238791 [TBL] [Abstract][Full Text] [Related]
30. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis. Sabbagh S; Pinal-Fernandez I; Kishi T; Targoff IN; Miller FW; Rider LG; Mammen AL; Ann Rheum Dis; 2019 Jul; 78(7):988-995. PubMed ID: 31018961 [TBL] [Abstract][Full Text] [Related]
31. Clinical and autoantibody phenotypes of juvenile dermatomyositis. Boyarchuk O; Kuka A; Yuryk I Reumatologia; 2022; 60(4):281-291. PubMed ID: 36186835 [TBL] [Abstract][Full Text] [Related]
32. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort. Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203 [TBL] [Abstract][Full Text] [Related]
33. Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis. Karasawa R; Yudoh K; Sato T; Tanaka M; Tamaki M; Sabbagh SE; O'Hanlon TP; Noroozi-Farhadi P; Targoff IN; Flegel WA; Mammen AL; Miller FW; Hicar MD; Rider LG; Jarvis JN Rheumatology (Oxford); 2022 Jul; 61(7):2969-2977. PubMed ID: 34791087 [TBL] [Abstract][Full Text] [Related]
34. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review]. Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559 [No Abstract] [Full Text] [Related]
35. Efficacy and tolerance of corticosteroids and methotrexate in patients with juvenile dermatomyositis: a retrospective cohort study. Dabbak I; Rodero MP; Aeschlimann FA; Authier FJ; Bodemer C; Quartier P; Bondet V; Charuel JL; Duffy D; Gitiaux C; Bader-Meunier B Rheumatology (Oxford); 2022 Nov; 61(11):4514-4520. PubMed ID: 35199139 [TBL] [Abstract][Full Text] [Related]
36. Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM). Abdul-Aziz R; Yu CY; Adler B; Bout-Tabaku S; Lintner KE; Moore-Clingenpeel M; Spencer CH Pediatr Rheumatol Online J; 2017 Apr; 15(1):25. PubMed ID: 28403889 [TBL] [Abstract][Full Text] [Related]
37. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies. Li S; Ge Y; Yang H; Wang T; Zheng X; Peng Q; Lu X; Wang G Clin Rheumatol; 2019 Aug; 38(8):2171-2179. PubMed ID: 30863950 [TBL] [Abstract][Full Text] [Related]